- News + Events
- Visit Now
- Apply Now
Athens, OHIO (April 14, 2014) -- Grady Carlson, a Ph.D. candidate in chemical and biomolecular engineering at the Fritz J. and Dolores H. Russ College of Engineering and Technology, has been honored with an invitation to the 64th Lindau Nobel Laureate Meeting in Physiology and Medicine this summer in Lindau, Germany.
Carlson will join a prestigious group of nearly 600 young researchers representing 80 countries to discuss molecular, genetic and cellular mechanisms as keys to preventing and healing diseases in a series of lectures, discussions and master classes with 37 Nobel Laureates.
“An international selection committee has essentially deemed him one of the best young researchers worldwide in medicine and physiology,” said Associate Professor of Chemical and Biomedical Engineering Monica Burdick, Carlson’s research advisor. “Now with presentations at major science and engineering conferences, published manuscripts and the invitation to the Lindau Nobel Laureate Meeting, the broader research community sees what we at Ohio University see in Grady.”
Carlson’s research into cancer diagnostics in Burdick’s lab earned him the invitation to Lindau. Much of Carlson’s work is focused on researching a novel tissue analysis, called dynamic biochemical tissue analysis (DBTA), that differentiates between non-cancerous and cancerous tissues and assesses the metastatic potential of a cancer.
By researching this method, which examines both the biochemical and biophysical properties of target cell adhesion molecules that play a role in cancer metastasis, Carlson is studying how to better predict the metastatic potential of a cancer by examining functional cancer biomarkers presented on cancerous tissues.
The Nobel Laureates will be meeting with the aspiring young researchers to share their knowledge, establish new contacts and discuss relevant topics such as global health, the challenges to medical care in developing countries or future research approaches to medicine.
In addition to scientific achievements, applicants must also demonstrate motivation to see their work influence the future of medicine. Participants are considered the next generation of leading researchers in the field.
By researching novel techniques and methods for targeting cancer biomarkers, Carlson’s ultimate goal is to help improve the survival rates of breast and colon cancer patients.
After completing his Ph.D. in May 2016, Carlson hopes to work as a research scientist with a focus on international collaboration.
“I feel blessed to have the opportunity to meet with the Nobel Laureates and an international community of my peers,” Carlson said. “I am proud to represent the Department of Chemical and Biomolecular Engineering, the Russ College of Engineering and Technology and Ohio University at the 64th Lindau Nobel Leaureate meeting.”